Pulmonary Embolism
Conditions
Brief summary
Following the implementation of SPECT V/Q imaging for PE diagnosis, the investigators previously conducted an observational study over the period 2011-2013 that showed the safety of a diagnostic management based on SPECT V/Q to rule out PE. However, PE prevalence was high (28%), which may seem a bit high as compared with other recent studies. The hypothesis was that the use of SPECT V/Q may be responsible for an overdiagnosis of PE, especially at the implementation phase of the test. The aim of this study was to perform a time trend analysis of the evolution over the years of PE diagnosis with SPECT V/Q.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* Patients who underwent a SPECT V/Q scan performed for a suspected acute PE in the Nuclear Medicine Department of Brest University Hospital from April 2011 to December 2016
Exclusion criteria
* Patient under legal or judicial protection * Patient opposed to the use of his medical data for research.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Diagnostic conclusion of all SPECT V/Q scans performed for a suspected acute PE | April 2011 to December 2016 | positive, negative, or non-conclusive |
Secondary
| Measure | Time frame |
|---|---|
| Risk of thromboembolic events (i.e. objectively confirmed pulmonary embolism or proximal deep vein thrombosis) during the 3-month follow-up period in patients left untreated based on a negative SPECT V/Q. | up to 3 Months following the date of the SPECT V/Q scan |
Countries
France